Biogen Pharmachem Stock Screener | Share Price & Fundamental Analysis
BIOGEN
Other Financial Services
Screen Biogen Pharmachem share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price BSE
₹0.76
▲
0.02 (2.70%)
Market Cap
₹66.81 Cr.
P/B Ratio
0.66
EPS (TTM)
-
Dividend Yield
-
Debt to Equity
-
52W High
₹1.18
52W Low
₹0.69
Operating Margin
-
Profit Margin
66.67%
Revenue (TTM)
₹3.00
EBITDA
₹2.00
Net Income
₹2.00
Total Assets
₹92.00
Total Equity
₹92.00
Biogen Pharmachem Share Price History - Stock Screener Chart
Screen BIOGEN historical share price movements with interactive charts. Analyze price trends and patterns.
Biogen Pharmachem Company Profile - Fundamental Screener
Screen Biogen Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for BIOGEN shares.
Sector
Financial Services
Industry
Other Financial Services
Sub-Sector
Other Financial Services
Segment
E
ISIN
INE703D01023
Biogen Pharmachem Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen BIOGEN balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 92 | 57 | 55 | 55 | 54 | 56 | 58 | 56 | 63 | 69 |
| Current Assets | 3 | 0 | 0 | 2 | 3 | 8 | 8 | 7 | 0 | 14 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Liabilities | ||||||||||
| Total Liabilities | 92 | 57 | 55 | 55 | 54 | 56 | 58 | 56 | 63 | 69 |
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 8 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 92 | 57 | 55 | 54 | 54 | 56 | 54 | 54 | 61 | 61 |
| Share Capital | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 | 65 |
| Reserves & Surplus | -9 | -9 | -11 | -11 | -11 | -10 | -11 | -11 | -4 | -4 |
Screen BIOGEN income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 3 | 1 | 2 | 1 | 3 | 2 | 0 | 1 | 0 | 0 | 0 | 0 |
| Expenses | 1 | 2 | 1 | 1 | 3 | 3 | 0 | 1 | 7 | 0 | 0 | 0 |
| EBITDA | 2 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Operating Profit % | 0.00% | 0.00% | 0.00% | 0.00% | -1.00% | -99.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 2 | 0 | 2 | 1 | 0 | -2 | 0 | 0 | -7 | 0 | 0 | 0 |
| EPS | 0.00 | 0.00 | 0.03 | 0.01 | 0.00 | -0.02 | 0.00 | 0.00 | -0.10 | 0.00 | 0.00 | 0.00 |
Biogen Pharmachem Cash Flow Screener - Liquidity Fundamentals
Screen BIOGEN cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | -1 | 2 | 2 | 1 | 4 | -1 | 0 | -14 | 0 | 5 |
| Investing Activities | -33 | -2 | -2 | -1 | -4 | 2 | -1 | 14 | 4 | 17 |
| Financing Activities | 36 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -4 | -22 |
| Net Cash Flow | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Screen BIOGEN shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 76.46% | 55.33% | 55.38% | 76.85% | 76.85% | 76.29% | 76.46% | 76.85% |
| Other Holding | 23.54% | 44.67% | 44.62% | 23.15% | 23.15% | 23.71% | 23.54% | 23.15% |
| Shareholder Count | 302,362 | 303,922 | 293,327 | 197,757 | 197,795 | 280,600 | 303,780 | 197,828 |
Biogen Pharmachem Dividend Screener - Share Yield Analysis
Screen BIOGEN dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Biogen Pharmachem Index Membership - Market Screener Classification
Screen BIOGEN by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Biogen Pharmachem Market Events Screener - Corporate Actions
Screen BIOGEN market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | 0.77% | ||
| Annual General Meeting | NA | -3.30% | ||
| 2025-11-07 | 2025-11-07 | Quarterly Result Announcement | NA | -2.41% |
| 2025-07-23 | 2025-07-23 | Quarterly Result Announcement | NA | -1.06% |
| 2025-05-23 | 2025-05-23 | Quarterly Result Announcement | NA | 22.89% |
| 2025-02-05 | 2025-02-05 | Quarterly Result Announcement | NA | 0.00% |
| 2024-11-13 | 2024-11-13 | Quarterly Result Announcement | NA | -2.34% |
| 2024-02-01 | 2024-02-01 | Extraordinary General Meeting | NA | -10.53% |
| 2021-01-22 | 2021-01-22 | Change Of Name | NA | 0.00% |
Biogen Pharmachem Competitors Screener - Peer Comparison
Screen BIOGEN competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Spice Lounge Food Works | 2,779 | 379.70 | 106 | % | 6 | 34.86 |
| Algoquant Fintech | 1,683 | 99.41 | 235 | 49.78% | 32 | 49.61 |
| LKP Finance | 1,521 | 827.37 | 14 | -84.02% | 2 | 64.45 |
| Wealth First Portfolio Managers | 986 | 31.47 | 60 | -10.30% | 34 | 35.98 |
| Prime Securities | 933 | 27.85 | 89 | 34.23% | 39 | 40.31 |
| Arunis Abode | 807 | 55.17 | 1 | -70.59% | 0 | 70.17 |
| RNFI Services | 783 | 39.46 | 923 | -2.09% | 20 | 39.59 |
| Investment Trust of India | 611 | 21.88 | 365 | 19.40% | 46 | 40.91 |
| Delphi World Money | 383 | 196.21 | 9,189 | 19.34% | 2 | 45.67 |
| NDL Ventures | 303 | 1,152 | 14.25% | 2 | 50.78 |
Biogen Pharmachem Company Announcements - News Screener
Screen BIOGEN latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-12-20 | Closure of Trading Window | View |
| 2025-11-07 | Disclosure Under Regulation 32(1) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-07 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-07 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-11-07 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 7Th November 2025. | View |
| 2025-10-30 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting | View |
| 2025-10-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-26 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-25 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-08-25 | Reg. 34 (1) Annual Report. | View |
| 2025-08-25 | Intimation Of Book Closure Pursuant To Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-08-25 | Submission Of Notice Of Annual General Meeting Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-23 | Nil Statement On Deviation Or Variation Of Funds Raised Through Preferential Issue | View |
| 2025-07-23 | Regulations 30 33 And Other Applicable Provisions Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | View |
| 2025-07-23 | Board Meeting Outcome for Outcome Of The Board Meeting Of The Board Held On 23Rd July 2025. | View |
| 2025-07-16 | Board Meeting Intimation for Compliance Of Regulation 29 Of SEBI (LODR) Regulations 2015 - Intimation Of Board Meeting. | View |
| 2025-07-04 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-06-26 | Closure of Trading Window | View |